{"id":5171,"date":"2022-03-12T14:39:19","date_gmt":"2022-03-12T14:39:19","guid":{"rendered":"https:\/\/www.nfp-drugs.bg\/en\/?p=5171"},"modified":"2024-01-22T15:40:20","modified_gmt":"2024-01-22T15:40:20","slug":"drugnet-europe-newsletter-of-the-european-monitoring-centre-for-drugs-and-drug-addiction","status":"publish","type":"post","link":"https:\/\/www.nfp-drugs.bg\/en\/drugnet-europe-newsletter-of-the-european-monitoring-centre-for-drugs-and-drug-addiction\/","title":{"rendered":"Drugnet Europe (Newsletter of the European Monitoring Centre for Drugs and Drug Addiction)"},"content":{"rendered":"\n

(100) Drugnet Europe – Newsletter of the EMCCDA (October – December 2017)<\/a>\u00a0<\/a><\/p>\n\n\n\n

(99) Drugnet Europe – Newsletter of the EMCDDA (July – September 2017)<\/a><\/p>\n\n\n\n

(98) Drugnet Europe – Newsletter of the EMCDDA (April – June 2017)<\/a><\/p>\n\n\n\n

(97) Drugnet Europe – Newsletter of the EMCDDA (January – March 2017)<\/a><\/p>\n\n\n\n

(96) Drugnet Europe – Newsletter of the EMCCDA (October – December 2016)<\/a><\/p>\n\n\n\n

(95) Drugnet Europe – Newsletter of the EMCDDA (July – September 2016)<\/a><\/p>\n\n\n\n

(94) Drugnet Europe – Newsletter of the EMCDDA (April – June 2016)<\/a><\/p>\n\n\n\n

(93) Drugnet Europe – Newsletter of the EMCDDA (January – March 2016)<\/a><\/p>\n\n\n\n

(92) Drugnet Europe – Newsletter of the EMCDDA (October – December 2015)<\/a><\/p>\n\n\n\n

(91) Drugnet Europe – Newsletter of the EMCDDA (July – September 2015)<\/a><\/p>\n\n\n\n

(90) Drugnet Europe – Newsletter of the EMCDDA (April – June 2015)<\/a><\/p>\n\n\n\n

(89) Drugnet Europe – Newsletter of the EMCDDA (January – March 2015)<\/a><\/p>\n\n\n\n

(88) Drugnet Europe – Newsletter of the EMCDDA (October – December 2014)<\/a><\/p>\n\n\n\n

(87) Drugnet Europe – Newsletter of the EMCDDA (July – September 2014)<\/a><\/p>\n\n\n\n

(86) Drugnet Europe – Newsletter of the EMCDDA (April – June 2014)<\/a><\/p>\n\n\n\n

(85) Drugnet Europe – Newsletter of the EMCDDA (January – March 2014)<\/a><\/p>\n\n\n\n

(84) Drugnet Europe – Newsletter of the EMCDDA (October – December 2013)<\/a><\/p>\n\n\n\n

(83) Drugnet Europe – Newsletter of the EMCDDA (July – September 2013)<\/a><\/p>\n\n\n\n

(82) Drugnet Europe – Newsletter of the EMCDDA (April – June 2013)<\/a><\/p>\n\n\n\n

(81) Drugnet Europe – Newsletter of the EMCDDA (January – March 2013)<\/a><\/p>\n\n\n\n

(80) Drugnet Europe – Newsletter of the EMCDDA (October – December 2012)<\/a><\/p>\n\n\n\n

(79) Drugnet Europe – Newsletter of the EMCDDA (July – September 2012)<\/a><\/p>\n\n\n\n

(78) Drugnet Europe – Newsletter of the EMCDDA (April – June 2012)<\/a><\/p>\n\n\n\n

(77) Drugnet Europe – Newsletter of the EMCDDA (January – March 2012)<\/a><\/p>\n\n\n\n

(76) Drugnet Europe – Newsletter of the EMCDDA (October – December 2011)<\/a><\/p>\n\n\n\n

(75) Drugnet Europe – Newsletter of the EMCDDA (July – September 2011)<\/a><\/p>\n\n\n\n

(74) Drugnet Europe – Newsletter of the EMCDDA (April – June 2011)<\/a><\/p>\n\n\n\n

(73) Drugnet Europe – Newsletter of the EMCDDA (January – March 2011)<\/a><\/p>\n\n\n\n

(72) Drugnet Europe – Newsletter of the EMCDDA (October – December 2010)<\/a><\/p>\n\n\n\n

(71) Drugnet Europe – Newsletter of the EMCDDA (July – September 2010)<\/a><\/p>\n\n\n\n

(70) Drugnet Europe – Newsletter of the EMCDDA (April – June 2010)<\/a><\/p>\n\n\n\n

(69) Drugnet Europe – Newsletter of the EMCDDA (January – March 2010)<\/a><\/p>\n\n\n\n

(68) Drugnet Europe – Newsletter of the EMCDDA (October – December 2009)<\/a><\/p>\n\n\n\n

(67) Drugnet Europe – Newsletter of the EMCDDA (July – September 2009)<\/a><\/p>\n\n\n\n

(66) Drugnet Europe – Newsletter of the EMCDDA (April – June 2009)<\/a><\/p>\n\n\n\n

(65) Drugnet Europe – Newsletter of the EMCDDA (January – March 2009)<\/a><\/p>\n\n\n\n

(64) Drugnet Europe – Newsletter of the EMCDDA (October – December 2008)<\/a><\/p>\n\n\n\n

(63) Drugnet Europe – Newsletter of the EMCDDA (July – September 2008)<\/a><\/p>\n\n\n\n

(62) Drugnet Europe – Newsletter of the EMCDDA (April – June 2008)<\/a><\/p>\n\n\n\n

(61) Drugnet Europe – Newsletter of the EMCDDA (January – March 2008)<\/a><\/p>\n\n\n\n

(60) Drugnet Europe – Newsletter of the EMCDDA (October – December 2007)<\/a><\/p>\n\n\n\n

(59) Drugnet Europe – Newsletter of the EMCDDA (July – September 2007)<\/a><\/p>\n\n\n\n

(58) Drugnet Europe – Newsletter of the EMCDDA (April – June 2007)<\/a><\/p>\n\n\n\n

(57) Drugnet Europe – Newsletter of the EMCDDA (January – March 2007)<\/a><\/p>\n\n\n\n

(56) Drugnet Europe – Newsletter of the EMCDDA (October – December 2006)<\/a><\/p>\n\n\n\n

(55) Drugnet Europe – Newsletter of the EMCDDA (July – September 2006)<\/a><\/p>\n\n\n\n

(54) Drugnet Europe – Newsletter of the EMCDDA (April – June 2006)<\/a><\/p>\n\n\n\n

(53) Drugnet Europe – Newsletter of the EMCDDA (January – March 2006)<\/a><\/p>\n\n\n\n

(52) Drugnet Europe – Newsletter of the EMCDDA (October – December 2005)<\/a><\/p>\n\n\n\n

(51) Drugnet Europe – Newsletter of the EMCDDA (July – September 2005)<\/a><\/p>\n\n\n\n

(50) Drugnet Europe – Newsletter of the EMCDDA (April – June 2005)<\/a><\/p>\n\n\n\n

(49) Drugnet Europe – Newsletter of the EMCDDA (January – March 2005)<\/a><\/p>\n\n\n\n

(48) Drugnet Europe – Newsletter of the EMCDDA (October – December 2004)<\/a><\/p>\n\n\n\n

(47) Drugnet Europe – Newsletter of the EMCDDA (July – September 2004)<\/a><\/p>\n\n\n\n

(46) Drugnet Europe – Newsletter of the EMCDDA (April – June 2004)<\/a><\/p>\n\n\n\n

(45) Drugnet Europe – Newsletter of the EMCDDA (January – March 2004)<\/a><\/p>\n\n\n\n

(44) Drugnet Europe – Newsletter of the EMCDDA (November – December 2003)<\/a><\/p>\n\n\n\n

(43) Drugnet Europe – Newsletter of the EMCDDA (September – October 2003)<\/a><\/p>\n\n\n\n

(42) Drugnet Europe – Newsletter of the EMCDDA (July – August 2003)<\/a><\/p>\n\n\n\n

(41) Drugnet Europe – Newsletter of the EMCDDA (May – June 2003)<\/a><\/p>\n\n\n\n

(40) Drugnet Europe – Newsletter of the EMCDDA (March – April 2003)<\/a><\/p>\n\n\n\n

(39) Drugnet Europe – Newsletter of the EMCDDA (January – February 2003)<\/a><\/p>\n\n\n\n

(38) Drugnet Europe – Newsletter of the EMCDDA (November – December 2002)<\/a><\/p>\n\n\n\n

(37) Drugnet Europe – Newsletter of the EMCDDA (September – October 2002)<\/a><\/p>\n\n\n\n

(36) Drugnet Europe – Newsletter of the EMCDDA (July – August 2002)<\/a><\/p>\n\n\n\n

(35) Drugnet Europe – Newsletter of the EMCDDA (May – June 2002)<\/a><\/p>\n\n\n\n

(34) Drugnet Europe – Newsletter of the EMCDDA (March – April 2002)<\/a><\/p>\n\n\n\n

(33) Drugnet Europe – Newsletter of the EMCDDA (January – February 2002)<\/a><\/p>\n\n\n\n

(32) Drugnet Europe – Newsletter of the EMCDDA (November – December 2001)<\/a><\/p>\n\n\n\n

(31) Drugnet Europe – Newsletter of the EMCDDA (September – October 2001)<\/a><\/p>\n\n\n\n

(30) Drugnet Europe – Newsletter of the EMCDDA (July – August 2001)<\/a><\/p>\n\n\n\n

(29) Drugnet Europe – Newsletter of the EMCDDA (May – June 2001)<\/a><\/p>\n\n\n\n

(28) Drugnet Europe – Newsletter of the EMCDDA (March – April 2001)<\/a><\/p>\n\n\n\n

(27) Drugnet Europe – Newsletter of the EMCDDA (January – February 2001)<\/a><\/p>\n\n\n\n

(26) Drugnet Europe – Newsletter of the EMCDDA (November – December 2000)<\/a><\/p>\n\n\n\n

(25) Drugnet Europe – Newsletter of the EMCDDA (September – October 2000)<\/a><\/p>\n\n\n\n

(24) Drugnet Europe – Newsletter of the EMCDDA (July – August 2000)<\/a><\/p>\n\n\n\n

(23) Drugnet Europe – Newsletter of the EMCDDA (May – June 2000)<\/a><\/p>\n\n\n\n

(22) Drugnet Europe – Newsletter of the EMCDDA (March – April 2000)<\/a><\/p>\n\n\n\n

(21) Drugnet Europe – Newsletter of the EMCDDA (January – February 2000)<\/a><\/p>\n\n\n\n

(20) Drugnet Europe – Newsletter of the EMCDDA (November – December 1999)<\/a><\/p>\n\n\n\n

(19) Drugnet Europe – Newsletter of the EMCDDA (September – October 1999)<\/a><\/p>\n\n\n\n

(18) Drugnet Europe – Newsletter of the EMCDDA (July – August 1999)<\/a><\/p>\n\n\n\n

(17) Drugnet Europe – Newsletter of the EMCDDA (May – June 1999)<\/a><\/p>\n\n\n\n

(16) Drugnet Europe – Newsletter of the EMCDDA (March – April 1999)<\/a><\/p>\n\n\n\n

(15) Drugnet Europe – Newsletter of the EMCDDA (January – February 1999)<\/a><\/p>\n\n\n\n

(14) Drugnet Europe – Newsletter of the EMCDDA (November – December 1998)<\/a><\/p>\n\n\n\n

(13) Drugnet Europe – Newsletter of the EMCDDA (September – October 1998)<\/a><\/p>\n\n\n\n

(12) Drugnet Europe – Newsletter of the EMCDDA (July – August 1998)<\/a><\/p>\n\n\n\n

(11) Drugnet Europe – Newsletter of the EMCDDA (May – June 1998)<\/a><\/p>\n\n\n\n

(10) Drugnet Europe – Newsletter of the EMCDDA (March – April 1998)<\/a><\/p>\n\n\n\n

(9) Drugnet Europe – Newsletter of the EMCDDA (January – February 1998)<\/a><\/p>\n\n\n\n

(8) Drugnet Europe – Newsletter of the EMCDDA (November – December 1997)<\/a><\/p>\n\n\n\n

(7) Drugnet Europe – Newsletter of the EMCDDA (September – October 1997)<\/a><\/p>\n\n\n\n

(6) Drugnet Europe – Newsletter of the EMCDDA (July – August 1997)<\/a><\/p>\n\n\n\n

(5) Drugnet Europe – Newsletter of the EMCDDA (May – June 1997)<\/a><\/p>\n\n\n\n

(4) Drugnet Europe – Newsletter of the EMCDDA (M<\/a>arch – April 1997)<\/p>\n\n\n\n

(3) Drugnet Europe – Newsletter of the EMCDDA (January – February 1997)<\/a><\/p>\n\n\n\n

(2) Drugnet Europe – Newsletter of the EMCDDA (November – December 1996)<\/a><\/p>\n\n\n\n

(1) Drugnet Europe – Newsletter of the EMCDDA (September – October 1996)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

(100) Drugnet Europe – Newsletter of the EMCCDA (October – December 2017)\u00a0 (99) Drugnet Europe – Newsletter of the EMCDDA (July – September 2017) (98) Drugnet Europe – Newsletter of the EMCDDA (April – June 2017) (97) Drugnet Europe – Newsletter of the EMCDDA (January – March 2017) (96) Drugnet Europe – Newsletter of the […]<\/p>\n","protected":false},"author":1,"featured_media":5167,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[57,59,58],"_links":{"self":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/5171"}],"collection":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/comments?post=5171"}],"version-history":[{"count":7,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/5171\/revisions"}],"predecessor-version":[{"id":6261,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/5171\/revisions\/6261"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media\/5167"}],"wp:attachment":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media?parent=5171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/categories?post=5171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/tags?post=5171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}